Life science quality
trends report 2024
We asked 2000 global life science quality professionals to share their lessons, headaches, working styles and plans with us in our third annual survey.
Quality & compliance targets for 2024
38% of medical device companies aim to achieve EU MDR or IVDR compliance in 2024.
Over a third of pharma and biotech companies have no new plans.
EU MDR/IVDR
38%
ISO 13485
30%
FDA 21 CFR 820
27%
None
24%
ISO 14971
22%
GMP
11%
None
36%
ISO 9001
21%
FDA QMM* program
16%
GMP
14%
PIC/S
12%
ICH Q guidelines
5%
Impact of an eQMS
Going digital pays off
9%
No
91%
Yes
18%
No
82%
Yes
Stats and metrics
Most common KPIs tracked by life science quality professionals
Training (completed, outstanding, etc.)
71.6%
Non-conformances (closure time, outstanding, etc.)
68.4%
Documentation (read, signed, etc.)
67.4%
Customer satisfaction (complaints, feedback, returns)
50.5%
Suppliers (RPPM, SCARs)
50.5%
Defects/faults
32.6%
Rework/first pass yield
22.1%
Right-first-time %
22.1%
Cost of poor quality (COPQ)
21.1%
None
4.2%
Other
4.2%
1-10
13.7%
11-50
24.2%
51-200
29.5%
201-500
17.9%
500+
14.7%
1-10
13.7%
11-50
24.2%
51-200
29.5%
201-500
17.9%
500+